⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for high performance liquid chromatography

Every month we try and update this database with for high performance liquid chromatography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateNCT00459407
Adenocarcinoma ...
Stage I Prostat...
Stage II Prosta...
defined green t...
placebo
immunohistochem...
immunoenzyme te...
laboratory biom...
biopsy
mass spectromet...
high performanc...
18 Years - National Cancer Institute (NCI)
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic CancerNCT00547612
Pancreatic Canc...
high performanc...
pharmacological...
[18F]-labeled s...
18 Years - National Institutes of Health Clinical Center (CC)
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00770471
Brain and Centr...
temozolomide
veliparib
DNA methylation...
gene expression...
mutation analys...
proteomic profi...
high performanc...
immunoenzyme te...
laboratory biom...
mass spectromet...
pharmacogenomic...
pharmacological...
adjuvant therap...
radiation thera...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerNCT00516698
Breast Cancer
polymorphism an...
high performanc...
laboratory biom...
radiomammograph...
18 Years - Alliance for Clinical Trials in Oncology
Liver Cancer Prevention Trial in Patients With Chronic Hep C InfectionNCT00513461
Adult Primary L...
Hepatitis C Inf...
S-adenosyl-L-me...
placebo
laboratory biom...
immunoenzyme te...
high performanc...
18 Years - University of California, Irvine
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerNCT00516698
Breast Cancer
polymorphism an...
high performanc...
laboratory biom...
radiomammograph...
18 Years - Alliance for Clinical Trials in Oncology
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy VolunteersNCT00984919
Prostate Cancer
high performanc...
laboratory biom...
mass spectromet...
40 Years - 120 YearsBarbara Ann Karmanos Cancer Institute
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaNCT00691652
Lymphoma
rituximab
clofarabine
DNA methylation...
gene expression...
microarray anal...
polymerase chai...
high performanc...
laboratory biom...
18 Years - 89 YearsOHSU Knight Cancer Institute
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid TumorsNCT01206465
Unspecified Adu...
pralatrexate
fluorouracil
laboratory biom...
DNA analysis
high performanc...
polymerase chai...
nucleic acid se...
pharmacological...
pharmacogenomic...
polymorphism an...
19 Years - University of Nebraska
White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer SurvivorsNCT00709020
Breast Cancer
Cancer Survivor
white button mu...
flow cytometry
high performanc...
laboratory biom...
mass spectromet...
pharmacogenomic...
pharmacological...
21 Years - City of Hope Medical Center
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in WomenNCT00900367
Breast Cancer
high performanc...
laboratory biom...
spectroscopy
- 120 YearsBrigham and Women's Hospital
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00714181
Unspecified Adu...
hydroxychloroqu...
temozolomide
TdT-mediated dU...
western blottin...
electron micros...
high performanc...
immunoenzyme te...
immunohistochem...
laboratory biom...
mass spectromet...
pharmacological...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid TumorsNCT00550901
Unspecified Adu...
cisplatin
dexrazoxane hyd...
high performanc...
laboratory biom...
mass spectromet...
pharmacological...
18 Years - City of Hope Medical Center
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy VolunteersNCT00984919
Prostate Cancer
high performanc...
laboratory biom...
mass spectromet...
40 Years - 120 YearsBarbara Ann Karmanos Cancer Institute
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast CancerNCT00569543
Breast Cancer
high performanc...
laboratory biom...
mass spectromet...
medical chart r...
19 Years - University of Nebraska
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant MelanomaNCT00661336
Melanoma (Skin)
buthionine sulf...
melphalan
microarray anal...
high performanc...
laboratory biom...
pharmacological...
biopsy
18 Years - Duke University
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00714181
Unspecified Adu...
hydroxychloroqu...
temozolomide
TdT-mediated dU...
western blottin...
electron micros...
high performanc...
immunoenzyme te...
immunohistochem...
laboratory biom...
mass spectromet...
pharmacological...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast CancerNCT00691509
Breast Cancer
gene expression...
polymorphism an...
high performanc...
laboratory biom...
mass spectromet...
questionnaire a...
- 75 YearsNational Cancer Institute (NCI)
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family MembersNCT00346008
Melanoma (Skin)
mutation analys...
high performanc...
laboratory biom...
questionnaire a...
- National Cancer Institute (NCI)
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant NeuroblastomaNCT00646230
Neuroblastoma
fenretinide
high performanc...
pharmacological...
0 Years - 30 YearsChildren's Hospital Los Angeles
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast CancerNCT00283608
Breast Cancer
Single nucleoti...
high performanc...
measurements by...
questionnaire a...
18 Years - Mayo Clinic
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNCT01383447
Philadelphia Ch...
Recurrent Adult...
entinostat
imatinib mesyla...
laboratory biom...
pharmacological...
western blottin...
immunohistochem...
flow cytometry
polymerase chai...
high performanc...
mass spectromet...
18 Years - National Cancer Institute (NCI)
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast CancerNCT00873366
Breast Cancer
dextromethorpha...
tamoxifen citra...
high performanc...
laboratory biom...
pharmacogenomic...
pharmacological...
fluorescence im...
18 Years - 120 YearsMayo Clinic
Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid TumorsNCT00645060
Unspecified Adu...
high performanc...
pharmacological...
radionuclide im...
single photon e...
yttrium Y 90 DO...
18 Years - 120 YearsCity of Hope Medical Center
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family MembersNCT00346008
Melanoma (Skin)
mutation analys...
high performanc...
laboratory biom...
questionnaire a...
- National Cancer Institute (NCI)
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryNCT01340599
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
defined green t...
placebo
immunohistochem...
immunoenzyme te...
questionnaire a...
therapeutic con...
high performanc...
mass spectromet...
45 Years - 75 YearsCase Comprehensive Cancer Center
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and ChemotherapyNCT00738452
Lung Cancer
high performanc...
pharmacological...
radionuclide im...
single photon e...
radiation thera...
yttrium Y 90 an...
18 Years - City of Hope Medical Center
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105NCT00959244
Breast Cancer
high performanc...
laboratory biom...
mass spectromet...
medical chart r...
19 Years - University of Nebraska
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal SurgeryNCT00973869
Colorectal Canc...
curcumin
high performanc...
laboratory biom...
pharmacological...
diagnostic endo...
therapeutic con...
18 Years - National Cancer Institute (NCI)
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast CancerNCT00569543
Breast Cancer
high performanc...
laboratory biom...
mass spectromet...
medical chart r...
19 Years - University of Nebraska
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionNCT00540982
Lung Cancer
Unspecified Adu...
indocyanine gre...
lidocaine
vinorelbine dit...
high performanc...
intracellular f...
liquid chromato...
mass spectromet...
pharmacological...
18 Years - 120 YearsCity of Hope Medical Center
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to TreatmentNCT00909831
Unspecified Adu...
hydroxychloroqu...
temsirolimus
electron micros...
high performanc...
immunologic tec...
laboratory biom...
mass spectromet...
pharmacological...
autophagy inhib...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105NCT00959244
Breast Cancer
high performanc...
laboratory biom...
mass spectromet...
medical chart r...
19 Years - University of Nebraska
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant MelanomaNCT00661336
Melanoma (Skin)
buthionine sulf...
melphalan
microarray anal...
high performanc...
laboratory biom...
pharmacological...
biopsy
18 Years - Duke University
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant NeuroblastomaNCT00646230
Neuroblastoma
fenretinide
high performanc...
pharmacological...
0 Years - 30 YearsChildren's Hospital Los Angeles
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: